SABS icon

SAB Biotherapeutics

42 hedge funds and large institutions have $24.5M invested in SAB Biotherapeutics in 2023 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
1
$6.31M
2
$6.31M
3
$3.16M
4
$3.15M
5
$1.63M
6
$1.26M
7
$685K
8
$555K
9
$348K
10
$245K
11
$191K
12
$132K
13
$60.5K
14
$55.9K
15
$47.4K
16
$43K
17
$36.2K
18
$36K
19
$35.7K
20
$32.7K
21
$31.9K
22
$30.6K
23
$15.8K
24
$11.5K
25
$11.2K